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Actinomycetes are bacteria belonging to the order Actinomycetales and are
characterized by the formation of branching filaments giving them a fungal appearance
(Lechevalier and Lechevalier, 1981). Actinomycetes are widespread in nature and can be
separated into two subgroups: oxidative forms, found mostly in soil habitants, and
fermentative forms, living in natural cavities of man and animals (Lechevalier and Pine,
1977).
Actinomycetes are very important from a medical point of view and are potential
human pathogens affecting both immunocompetent and immunocompromised hosts. The
latter number is steadily increasing because modern technology allows the prolonged
survival of critically ill patients, e.g. HIV-infected patients (McNeill and Brown, 1994).
A number of actinomycetes in the genus Streptomyces are also known as plant pathogens
but they play a minor role in plant diseases (Locci, 1994).
Common characteristics of the actinomycetes are formation of substrate- and aerial
mycelium on solid media, their Gram-positive character, presence of spores, and a high
















































































































Figure 1. Unrooted distance tree, based on 16S rRNA nucleotide sequences, showing the
relationships among members of the genera Saccharothrix, Actinokineospora, and members of
the family Pseudonocardiaceae. Bar = 10 substitutions per 1,000 bases. Reproduced from
Warwick et al. (1994). Inset: Unrooted phylogenetic tree showing the position of the family
Pseudonocardiaceae within the actinomycetes. Reproduced from Embley (1991).
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separated into different genera via morphological, physical, and chemical criteria. Most
actinomycetes possess cell wall type I to IV with peptidoglycans containing
L-diaminopimelic acid (DAP) and glycine (type I), meso-DAP and glycine (type II),
meso-DAP (type III), or meso-DAP, arabinose, and galactose (type IV) (Goodfellow,
1989). The genus Streptomyces is the best known representative with cell wall type I.
Micromonospora and Actinoplanes are genera with cell wall type II. Thermoactinomyces,
Microtetraspora, and Frankia are genera with cell wall type III. Cell wall type IV
actinomycetes comprise two families with (Mycobacteriaceae) or without
(Pseudonocardiaceae) mycolic acids (Embley, 1991). The family Pseudonocardiaceae
contains the genera Amycolatopsis, Amycolata, Pseudonocardia, Saccharomonospora,
and Saccharopolyspora (Embley, 1991; Embley and Stackebrandt, 1994; Warwick et al.,
1994) (Fig. 1). Previously these genera were referred to as the Amycolata wall type IV
taxa or as Micropolysporas (Embley et al., 1988; Goodfellow and Cross, 1984).
Pseudonocardiaceae are metabolically diverse and comprise autotrophic,
methylotrophic, thermophilic, and halophilic family members.
SECONDARY METABOLISM
Actinomycetes are undoubtedly the largest producers of bacterial secondary
metabolites (Table 1). Secondary metabolites are, in contrast to primary metabolites, not
essential for growth and are synthesized from intermediates or end products of primary
metabolism via unique biosynthetic pathways. These pathways may have originated from
primary pathways within the same organism but also gene transfer between different
organisms is an important factor in the evolution of secondary metabolism (Vining, 1992).
A survey of the literature from 1988-1992 revealed more than one thousand new
secondary metabolites detected in actinomycetes. Most of the secondary metabolites
identified were produced by Streptomyces sp. (Sanglier et al., 1993). The taxonomy of
Streptomyces is not very clear and more detailed taxonomical studies undoubtedly will
result in transfer of organisms previously know as Streptomyces sp. into other genera.
Secondary metabolites are synthesized under suboptimal growth conditions near the
end of the exponential growth phase or in the stationary phase. Their formation is directed
by organized sets of genes associated with special regulatory mechanisms that control
both the timing and the level of gene expression (Horinouchi and Beppu, 1994; Liras et
al., 1990; Martin and Demain, 1980; Vining, 1992). Their physiological role is not known.
Speculations about their function include a role in overflow metabolism to get rid off
excessive amounts of intermediates of primary metabolism. High intracellular
concentrations of these intermediates can be toxic for the cell. If export of unmodified
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Class Common name Organism Reference
Aminoglycosides Streptomycin Streptomyces griseus Crandell and Hamill, 1986
Hygromycin Streptomyces hygroscopicus Crandell and Hamill, 1986
Neomycin Streptomyces fradiae Crandell and Hamill, 1986
Gentamicin Micromonospora spp. Crandell and Hamill, 1986
Kanamycin Streptomyces kanamyceticus Crandell and Hamill, 1986
Apramycin Streptomyces tenebrarius Crandell and Hamill, 1986
Spectinomycin Streptomyces spectabilis Crandell and Hamill, 1986
Ansamycins Rifamycin Amycolatopsis mediterranei Embley, 1991
Geldanamycin S. hygroscopicus Crandell and Hamill, 1986
Herbimycin S. hygroscopicus var. geldanus var. nova Crandell and Hamill, 1986
Streptovaricins S. spectabilis Crandell and Hamill, 1986
$-lactams Penicillins Streptomyces spp., Nocardia spp. Cohen et al., 1990
Cephalosporins Streptomyces spp., Nocardia spp. Cohen et al., 1990
Macrolides Oleandomycin Streptomyces antibioticus Crandell and Hamill, 1986
Erythromycin Saccharopolyspora erythraea Embley, 1991
Spiramycin Streptomyces ambofaciens Crandell and Hamill, 1986
Tylosin S. fradiae Crandell and Hamill, 1986
Nucleosides Sinefungin Streptomyces griseolus Crandell and Hamill, 1986
Tunicamycin S. griseolus Crandell and Hamill, 1986
Peptides Vancomycin Amycolatopsis orientalis Crandell and Hamill, 1986
Actinomycin S. antibioticus Crandell and Hamill, 1986
Thiostrepton Amycolatopsis azurea Crandell and Hamill, 1986
Avoparcin Amycolatopsis coloradensis Labeda, 1995
Orientisin A and B A. orientalis Embley, 1991
Muraceins A. orientalis Embley, 1991
Macrobicyclic peptide Amycolatopsis fastidiosa Embley, 1991
Azureomycin A and B A. azurea Embley, 1991
Polyenes Amphotericin B Streptomyces nodosus Crandell and Hamill, 1986
Nystatin Streptomyces nouresii Crandell and Hamill, 1986
Candicidin S. griseus Crandell and Hamill, 1986
Polyether antibiotics Monensin Streptomyces cinnamonensis Crandell and Hamill, 1986
Salinomycin Streptomyces albus Crandell and Hamill, 1986
Narasin Streptomyces aureofaciens Crandell and Hamill, 1986
Tetracyclines (Chlor-) Tetracycline S. aureofaciens Crandell and Hamill, 1986
Oxytetracyclin Streptomyces rimosus Crandell and Hamill, 1986
Cetocyline Amycolatopsis sulphurea Embley, 1991
Miscellaneous Chloramphenicol Streptomyces venezuelae Crandell and Hamill, 1986
Cycloserine Streptomyces sp. Crandell and Hamill, 1986
Rapamycin S. hygroscopicus Paiva et al., 1993
Lincomycin Streptomyces lincolnensis Crandell and Hamill, 1986




metabolites is not possible, their conversion into less toxic, or more easily exported
metabolites, may provide a way to prevent build up of toxic intermediates (Malik, 1980).
Several of the enzymes in secondary metabolism are also regulated via repression or
feedback inhibition making such a role in overflow metabolism less likely (Martin and
Demain, 1980). Another role for secondary metabolites may be in defence mechanisms.
Inhibiting other, competing cells, would leave more nutrients for the survival of the
secondary metabolite producing strain (Malik, 1980; Maplestone et al., 1992). Indeed
many secondary metabolites show anti-bacterial or other inhibitory activities
(anti-tumour, anti-fungal) or may function as herbicides (Demain, 1983; Malik, 1980;
Sanglier et al., 1993). Various groups of secondary metabolites can be distinguished
depending on the primary intermediate from which they are derived. This division,


































































herbimycins, macebins,  maytansoids, )
(actamycin, halomycins, naphthomcyin,
rifamycins, streptovaricins, tolypolmycins)
Figure 2. Secondary metabolites derived from (intermediates of) aromatic amino acid
biosynthesis in various actinomycetes. ---, multiple enzyme steps; ?, structural analog of the
proposed precursor but synthesis from it has not been proven (Dewick, 1989, 1995; Haslam,
1993).
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however, is not absolute because more than one primary metabolite may be involved in
the biosynthesis of a particular secondary metabolite.
The search for new secondary metabolites continues and if a more detailed
understanding of the physiology of actinomycetes is combined with increased
automatization of detection equipment, the list of known secondary metabolites
undoubtedly will grow even further (Bevan et al., 1995).
The prospects of isolating new anti-bacterial, -fungal, -tumour compounds,
herbicides, or pesticides, has stimulated interest in research of secondary metabolite
synthesis. Despite this, little attention has been paid thus far to primary metabolism in
actinomycetes and its regulation. Poor growth characteristics and difficulties encountered
in growing actinomycetes, have most likely contributed to this neglect. Identification of
primary metabolites involved in secondary metabolite biosynthesis and information about
the regulation of their synthesis is necessary to further increase the yield of secondary
metabolite production.
The first steps in secondary metabolite biosynthesis usually involve a series of very
specific enzymatic steps to synthesize a common building block. This compound is than
derivatized via nonspecific dehydrogenases, transferases, methyl-transferases, oxidases,
or other activities, acting in various combinations or sequences, resulting in an enormous
diversity of chemical compounds as end products. The exchange of genes coding for these
nonspecific enzymes, via natural recombination or recombinant DNA techniques, indeed
has lead to the formation of new hybrid secondary metabolites (metabolic pathway
engineering) (Decker et al., 1995; Ghisalba et al., 1984; Hopwood, 1995; McDaniel et
al., 1995; Piepersberg, 1994; Vournakis and Elander, 1983).
Mutagenesis and selection of strains overproducing secondary metabolites is
necessary to overcome the initially low rate of secondary metabolite synthesis. In the
initial strain improvement procedures, the flux of the specific secondary metabolite
biosynthetic pathways themselves may be increased in the production strains. Later, the
availability of precursors from primary metabolism will be of influence. At this stage one
may expect that increasing the flow towards these building blocks will also increase the
productivity of secondary metabolite formation.
An interesting group of secondary metabolites containing aromatic rings is derived
from intermediates of aromatic amino acid biosynthesis or the aromatic amino acids
themselves (Fig. 2). Many of these compounds are clinically important, especially
vancomycin and teicoplanin, glycopeptide antibiotics  active against  the methicillin
resistant Staphylococcus aureus (MRSA) (Brogden and Peters, 1994; Spencer and
Bryson, 1995).
Knowledge of the biosynthesis and regulation of aromatic amino acids in
actinomycetes is limited but will be of importance for further production strain
improvement. Aromatic amino acid biosynthesis is generally regulated very well due to
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the high energetic costs to synthesize these amino acids. Among the amino acids, aromatic
amino acids are the most expensive to synthesize (L-Phe: 65, L-Tyr: 62, and L-Trp: 78
ATP metabolic equivalents, respectively) (Atkinson, 1977).
THE SHIKIMATE PATHWAY
Shikimate is an organic acid first isolated from the fruits of Illicium religiosum and
Illicium anisatum where it is present in large quantities (up to 20%) (Eykmann, 1885,
1891). The name shikimate was derived from the Japanese name for the tree Illicium
religiosum, shikimi-no-ki (anise tree). About 60 years later it was discovered that
shikimate was an intermediate in aromatic amino acid biosynthesis in plants and
microorganisms (animals cannot carry out de novo synthesis of aromatic amino acids)























































































Figure 3. The shikimate pathway- Enzymes and intermediates of the common pathway. 1,
3-deoxy-D-arabino-heptulosonate 7-phosphate synthase; 2, 3-dehydroquinate synthase; 3,
3-dehydroquinate dehydratase, 4, NADP+-dependent shikimate dehydrogenase; 5, shikimate
kinase; 6, 5-enolpyruvyl-shikimate-3-phosphate synthase; 7, chorismate synthase; 8, NAD+- or
PQQ-dependent quinate/shikimate dehydrogenase; 9, 3-dehydroshikimate dehydratase.
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Biosynthesis of aromatic amino acids starts with a common pathway, the shikimate
pathway, leading to the branchpoint intermediate chorismate (Fig. 3). Chorismate can be
converted into anthranilate (L-Trp) or prephenate (L-Phe and L-Tyr). The sequence of
enzymatic steps and the intermediates in the shikimate pathway and the L-Trp pathway
are consistent throughout nature. The pathways to L-Phe and L-Tyr, however, show some
variations. L-Phe is synthesized via either phenylpyruvate and/or arogenate while L-Tyr
is synthesized via 4-hydroxyphenylpyruvate and/or arogenate. In some organisms both
pathways to L-Phe and L-Tyr are present (see below).
CHEMISTRY OF THE SHIKIMATE PATHWAY
Aromatic amino acids are synthesized from the central metabolites
phosphoenolpyruvate (PEP) and erythrose-4-phosphate (E4P). In the first step of the
shikimate pathway E4P and PEP are condensed into 3-deoxy-D-arabino-heptulosonate
7-phosphate (DAHP). The phosphate group of PEP is released as inorganic phosphate
after C-O cleavage leaving an active pyruvyl group which reacts with E4P into DAHP.
DAHP is converted into 3-dehydroquinate via ring closure through formation of a C-C
bond between C-2 and C-7 and release of inorganic phosphate. The formation of a double
bond in 3-dehydroquinate via the elimination of water between C-1 and C-2 results in
3-dehydroshikimate. Shikimate is synthesized via the reduction of the C-3 keto-group in
3-dehydroshikimate. A phosphate group is transferred from ATP to the C-3 hydroxyl in
the synthesis of shikimate-3-phosphate. A molecule of PEP is transferred to the C-5
position of shikimate-3-phosphate to yield 5-enolpyruvyl-shikimate-3-phosphate (EPSP)
and inorganic phosphate via, again a C-O cleavage of PEP and release of inorganic
phosphate. This pyruvyl group later will be the sidechain in L-Phe and L-Tyr and will be
lost as pyruvate in the formation of anthranilate, the precursor of L-Trp biosynthesis.
Chorismate is synthesized from EPSP via elimination of the C-6 hydrogen introducing
the second double bond and the release of inorganic phosphate from C-3 (Fig. 3).
ENZYMOLOGY OF THE SHIKIMATE PATHWAY
The enzymology of the shikimate pathway is covered in a range of excellent reviews
which, however, mainly deal with the biosynthesis of aromatic amino acids in
Gram-negative bacteria, (mostly Escherichia coli), yeast and plants (Bentley, 1990;
Braus, 1991; Byng et al., 1982; Camakaris and Pittard, 1983; Dewick, 1989,1995; Ganem,




All the genes coding for enzymes of L-Phe and L-Tyr biosynthesis have been cloned
from E. coli and their nucleotide sequence determined. From Bacillus subtilis and
Saccharomyces cerevisiae most genes have been cloned and sequenced. In Table 2, a
short summary is given about current knowledge of these genes, proteins, and the main
effectors of enzyme activity in these organisms.
In yeast and fungi a special arrangement of five of the seven enzymes of the shikimate
pathway is present. Five enzymatic activities, converting 3-dehydroquinate into EPSP,
are localized on a pentafunctional enzyme, the arom protein (Haslam, 1993). Most of the
research on the arom protein has been carried out in S. cerevisiae, Aspergillus nidulans
and Neurospora crassa. The arom protein consists of five domains, each showing
homology to the individual enzymes of for instance E. coli (Coggins et al., 1987b; Duncan
et al., 1987). The gene, aro1, encoding the arom protein can be split into five different
genes with the ability to complement corresponding E. coli mutants (Hawkins and Smith,
1991). Initially, channelling of substrates to the next active site was thought to be the
physiological role of this arom protein. In view of the substantial leakage of shikimate
pathway intermediates from the protein, this appears less likely (Lamb et al., 1991, 1992).
The function of this protein possibly is in the coordinate expression of a single gene
instead of five different genes (Duncan et al., 1988).
Escherichia coli Bacillus subtilis Saccharomyces cerevisiae
Enzyme Gene Sizea Sub-
units Reg Gene Size
Sub-
units Reg Gene Size
Sub-
units Reg
DS-tyr aroF 38804 2 Tyr ndb - - - aro4 39476 ?c Tyr
DS-phe aroG 38009 4 Phe nd - - - aro3 41070 1 Phe
DS-trp aroH 38602 2 Trp nd - - - nd - - -
DS-cha/ppa nd - - - aroA-G 39539 CM-SK cha/ppa nd - - -
DHQS aroB 38880 1 none aroB 40817 CS none
aro1
present as a dimeric,
pentafunctional protein
(arom) with subunit Mr of
174555
DHQD aroD 26407 2 none aroC 28099 2 none
SAdeh aroE 29380 1 none aroD ? ? ?
SKI aroK 19500 1 none aroI 21923 DS-CM cha/ppa
SKII aroL 18937 1 none nd - - -
EPSPS aroA 46112 1 none aroE 45240 ? none
CS aroC 38183 4 none aroF 39971 DHQS none aro2 40838 ? ?
P-protein pheA 43111 2 Phe nd - - - nd - - -
T-protein tyrA 42042 2 Tyr nd - - - nd - - -
CM nd - - - aroH 14479 2 none aro7 29747 2 Tyr,Trp
PDT nd - - - pheA 31901 multid multid pha2 ? ? Phe
PDH nd - - - tyrA 41434 ? Tyr tyr1 49649 ? Phe,Tyr
aro AT tyrB 43537 ? none aroJ ? ? none ? ? ? ?
a deduced from gene sequence; b not detectable; c no information available; d see text. For abbreviations and references , see text.
Table 2. Summary of genes and some properties of enzymes in the biosynthesis of aromatic
amino acid biosynthesis in E. coli, B. subtilis, and S. cerevisiae.
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In the following, current knowledge about the individual enzyme steps in aromatic
amino acid biosynthesis will be briefly reviewed. Where possible, available information
about Gram-positive bacteria and in particular actinomycete enzymes will be highlighted.
3-Deoxy-D-arabino-heptulosonate 7-phosphate synthase
The first enzyme in the shikimate pathway, 3-deoxy-D-arabino-heptulosonate
7-phosphate synthase (DS), converts PEP and E4P into DAHP. DS requires the presence
of divalent metal ions for activity (Fe, Co, or Mn). DS proteins possess the largest variety
of allosteric regulatory patterns thus far described for any protein (Bentley, 1990). They
can be divided into five major isoenzymes based on their sensitivity towards feedback
inhibition by L-Phe (DS-phe), L-Tyr (DS-tyr), L-Trp (DS-trp), chorismate and prephenate
(DS-cha/ppa), or no feedback inhibition (DS-o). Activity is usually inhibited by a single
aromatic amino acid or by a combination of L-Phe, L-Tyr, or L-Trp. In addition, DS
activity is inhibited by phenylpyruvate or 4-hydroxyphenylpyruvate in some organisms.
In E. coli three different DS isoenzymes are present. Each isoenzyme is effectively
feedback inhibited by a single aromatic amino acid. The DS isoenzymes are not expressed
equally. The ratio of the activities of DS-phe, DS-tyr, and DS-trp is approximately
75:25:<1 and is regulated via repression by the corresponding aromatic amino acid. The
three proteins are 41% identical, suggesting a common evolutionary origin. DS-phe is
considered evolved recently because it is present in the enteric lineage of the
Gram-negative Superfamily B only (Ahmad and Jensen, 1989; Ahmad et al., 1986).
Feedback inhibition of DS activity is a major control point for the carbon flow through
the shikimate pathway in E. coli (Ogino et al., 1982).
In S. cerevisiae two DS proteins are present, DS-phe and DS-tyr encoded by aro3 and
aro4, respectively. Both proteins have a high degree of similarity with the E. coli
isoenzymes. DS-phe and DS-tyr are also present in the yeasts Candida maltosa and
Hansenula henricii and in the fungus N. crassa an additional DS-trp is present (Bentley,
1990).
The B. subtilis and Bacillus licheniformis DS enzymes are inhibited by chorismate
and prephenate (Jensen and Nester, 1966a, 1966b; Nasser et al., 1969). In B. subtilis strain
168 both DS and chorismate mutase (CM) activity are located on a bifunctional protein.
Both the B. subtilis bifunctional and the B. licheniformis monofunctional DS proteins are
tetramers of Mr 180,000. CM activity on the bifunctional DS-CM protein arose from a
mutation in the prephenate feedback inhibition binding site to allow also binding of
chorismate and preferentially the transition state analog, thereby converting chorismate
into prephenate (Llewellyn et al., 1980). The gene, aroA-G, encoding the bifunctional
DS-CM from B. subtilis 168 encodes a protein with a Mr of 39,539 (Bolotin et al., 1992).
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In Brevibacterium flavum DS activity is synergistically inhibited by L-Phe and L-Tyr
and forms a bifunctional complex with CM. Activity of DS, a tetramer with a subunit Mr
of 55,000 is stimulated by the CM component (Shiio and Sugimoto, 1979; Shiio et al.,
1974).
In Corynebacterium glutamicum DS activity is synergistically inhibited by L-Phe and
L-Tyr and the inhibition is enhanced by L-Trp (Hagino and Nakayama, 1974b; Shiio et
al., 1974). The gene for C. glutamicum DS has been cloned and the deduced protein was
53% identical with the E. coli DS-phe protein and 48% and 47% with DS-trp and DS-tyr
proteins, respectively (Chen et al., 1993).
DS proteins have been characterized from a few actinomycetes only. In Streptomyces
rimosus (Stuart and Hunter, 1993), Streptomyces coelicolor (Walker, 1991),
Streptomyces antibioticus (Murphy and Katz, 1980) and Streptomyces aureofaciens
(Görisch and Lingens, 1971) a single DS is present that is inhibited by L-Trp only. No
evidence for additional DS activities in these bacteria was found. The DS activity of
Amycolatopsis (Nocardia) mediterranei was weakly inhibited by chorismate and by a
combination of L-Phe, L-Tyr, and L-Trp (Gygax et al., 1982). In Amycolatopsis
methanolica (Nocardia sp. 239) a single DS protein was reported, cumulatively inhibited
by L-Phe, L-Tyr, and L-Trp (main effector) (De Boer et al., 1989).
3-Dehydroquinate synthase
Conversion of DAHP into 3-dehydroquinate by 3-dehydroquinate synthase (DHQS)
requires specific oxidation, ß-elimination, reduction, and an intramolecular aldol
condensation. All these steps  are  catalysed  by a  single  enzyme,  3-dehydroquinate
dehydratase. It requires the presence of catalytic amounts of NAD+, and Co2+ or Zn2+
ions for activity (Bender et al., 1989). The impressive number of reactions mentioned
above appears to be the result of several kinetically feasible and thermodynamically
favourable processes. In reality, the enzyme may be no more than a simple dehydrogenase
with an enzyme bound NAD+ and a divalent metal ion required for activity (Haslam,
1993).
Only very little information is available about this protein in actinomycetes and other
Gram-positive bacteria. The gene coding for 3-dehydroquinate synthase has been cloned
from Mycobacterium tuberculosis revealing high similarity with 3-dehydroquinate
synthase  proteins from E. coli, A. nidulans, and S. cerevisiae. The Mr of the M.
tuberculosis 3-dehydroquinate synthase is 38,000 (Garbe et al., 1991). It was found
immediately upstream of the gene coding for 3-dehydroquinate dehydratase, the next
enzymatic step in the shikimate pathway (Garbe et al., 1991). Also in S. coelicolor an
open reading frame, immediately upstream of the 3-dehydroquinate dehydratase gene,
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encoded a protein showing high homology with 3-dehydroquinate synthase (Hunter,
1992).
In B. subtilis, 3-dehydroquinate synthase was associated with chorismate synthase and
NADPH-dependent flavin reductase. Activity of 3-dehydroquinate synthase was
completely dependent on the presence of chorismate synthase (Hasan and Nester, 1978).
The gene, aroF, encoding chorismate synthase was found immediately upstream of aroB,
the gene encoding 3-dehydroquinate synthase. Both genes are part of the supra operon
aroFBH-trpEDCFBA-hisH-tyrA-aroE (Babitzke et al., 1992).
3-Dehydroquinate dehydratase
3-Dehydroquinate dehydratase (DHQD) catalyses the formation of
3-dehydroshikimate from 3-dehydroquinate. Two forms of 3-dehydroquinate
dehydratase are known; type I, a biosynthetic enzyme present in for instance E. coli, and
type II, a catabolic enzyme usually present in organisms growing on quinate as a carbon
source. Quinate catabolism involves the enzymes quinate dehydrogenase,
3-dehydroquinate dehydratase, and 3-dehydroshikimate dehydratase (Fig. 3). The
catabolic type II enzyme can easily be distinguished from the biosynthetic type I variant.
Type II enzymes are thermostable and insensitive towards inactivation by NaBH4 in the
presence of 3-dehydroquinate (Kleanthous et al., 1992).
The B. subtilis 3-dehydroquinate dehydratase is probably a type I enzyme, as judged
from high sequence similarity with the E. coli type I enzyme (Yamamoto et al., 1991).
The type II 3-dehydroquinate dehydratase enzymes of for instance A. nidulans
(Kleanthous et al., 1992) and N. crassa (Hawkins et al., 1982) are dodecameric proteins.
They are induced in the presence of quinate and required for quinate catabolism. An
additional type I 3-dehydroquinate dehydratase in these organisms is present as a part of
the pentafunctional arom protein. Some genes encoding type II 3-dehydroquinate
dehydratase proteins have been cloned and the deduced proteins have no homology with
type I enzymes. The subunits of type II enzymes have a Mr of about 16,000, smaller than
the subunits of type I enzymes (Table 2).
Not only in fungi but also in bacteria, type I and type II enzymes may be present
simultaneously. In Acinetobacter calcoaceticus (Ingledew et al., 1971), Pseudomonas
aeruginosa (Ingledew and Tai, 1972), and in various actinomycetes (Cain, 1981), both
type I and type II 3-dehydroquinate dehydratases are present in quinate grown cells.
Type II enzymes (but not type I enzymes) are present in M. tuberculosis (Garbe et al.,
1991), S. coelicolor (White et al., 1990) and most likely also in various other
actinomycetes (Cain, 1981). Although these organisms possess a type II enzyme, they
are unable to grow on quinate. The enzyme, therefore, functions in aromatic amino acid
biosynthesis only. The M. tuberculosis 3-dehydroquinate dehydratase has been
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overexpressed and subsequently purified. Like other type II enzymes it is a dodecameric
thermostable protein (Moore et al., 1992). Crystals of the enzyme have been obtained
and attempts to determine its 3-dimensional structure are in progress (Gourley et al.,
1994).
Type I enzymes are inhibited by NaBH4 in the presence of 3-dehydroquinate. An
imine  intermediate  is formed between the active-site lysine and 3-dehydroquinate,
resulting in a Schiff’s base that can be reduced in a stable substrate-protein complex by
NaBH4 (Shneier et al., 1991). Type II enzymes cannot be inactivated in this way because
a different mechanism is used for the conversion of 3-dehydroquinate in which lysine
does not play a role (Garbe et al., 1991; Harris et al., 1993; Kleanthous et al., 1992;
Shneier et al., 1993). Inhibition studies with the arginine modifier phenylglyoxal
identified an arginine residue in the N-terminus of the type II 3-dehydroquinate
dehydratase protein that is essential for its activity (Krell et al., 1995). A preliminary
reaction mechanism based on the involvement of this arginine has been proposed (Krell
et al., 1995). An interesting aspect of type I and type II 3-dehydroquinate dehydratases
thus is that two different enzymes use different mechanisms (opposite stereo chemistry)
for the same conversion (Shneier et al., 1993).
Shikimate dehydrogenase
Shikimate dehydrogenase (SAdeh) catalyses the reduction of 3-dehydroshikimate.
Three types of shikimate dehydrogenase enzymes can be distinguished depending on the
involvement of either NAD+, NADP+, or pyrroloquinoline quinone (PQQ).
In all organisms studied the biosynthetic shikimate dehydrogenase enzyme is specific
for NADPH and 3-dehydroshikimate.
The NAD+-specific shikimate dehydrogenase is the first enzyme in shikimate
catabolism; it is also referred to as quinate dehydrogenase in view of its ability to convert
quinate into 3-dehydroquinate (Cain, 1972a). NAD+-dependent shikimate
dehydrogenases from Rhodococcus rhodochrous (Bruce and Cain, 1990), N. crassa
(Barea and Giles, 1978), and A. nidulans (Hawkins et al., 1988) are all monomeric
proteins of approximately Mr 40,000 and able to function as quinate dehydrogenases.
Significant sequence homology exists between the NAD+- and the NADP+-dependent
shikimate dehydrogenases, including the shikimate dehydrogenase domain from the arom
protein (Anton and Coggins, 1988).
A catabolic PQQ-dependent shikimate/quinate dehydrogenase has been characterized
(Van Kleef and Duine, 1988) and cloned from A. calcoaceticus (Elsemore and Ornston,
1994). No homology was found between the PQQ- and the NAD(P)+-dependent
shikimate dehydrogenase proteins. Other PQQ-dependent quinate/shikimate
dehydrogenases have not been described thus far.
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Shikimate kinase
Shikimate kinase (SK) catalyses the formation of shikimate-3-phosphate from
shikimate and ATP. In E. coli two shikimate kinases are present (Table 2). The higher
affinity of shikimate kinase II for shikimate and ATP suggested that it normally functions
in aromatic amino acid biosynthesis (DeFeyter and Pittard, 1986). Both shikimate kinase
I and II activity of E. coli are not feedback inhibited. Recent studies with E. coli aroK
showed that it is transcribed differently than originally reported. The new predicted Mr
of shikimate kinase I is now in accordance with the Mr of purified shikimate kinase I and
the protein is more homologous to other shikimate kinase enzymes (Griffin and Gasson,
1995; Whipp and Pittard, 1995).
In B. subtilis 168 shikimate kinase is active in a trifunctional complex with the
bifunctional DS-CM protein and is inhibited by chorismate and prephenate (Nakatsukasa
and Nester, 1972; Nasser et al., 1969). Such a complex was not present in B. licheniformis
indicating that this is not a common feature in Bacillus spp. (Nasser et al., 1969). The
activity of shikimate kinase in B. licheniformis was feedback inhibited by chorismate only
(Nasser et al., 1969). The gene, aroI, encoding shikimate kinase has been cloned from B.
subtilis; the deduced protein has 59% similarity with E. coli shikimate kinase II (Nakane
et al., 1994).
The shikimate kinase gene has also been cloned from Brevibacterium lactofermentum
and has been found in a cluster with the genes encoding 3-dehydroquinate synthase and
shikimate dehydrogenase but no sequence information is available yet (Matsui et al.,
1988). Activity of shikimate kinase was found to be limiting in B. lactofermentum strains
overproducing L-Tyr because an increase in its gene dosage stimulated/enhanced L-Tyr
production (Ito et al., 1990).
5-Enolpyruvyl-shikimate-3-phosphate synthase
5-Enolpyruvyl-shikimate-3-phosphate synthase (EPSPS) catalyses the formation of
EPSP from shikimate-3-phosphate and PEP. Only a few reports have been published
describing EPSP synthase of Gram-positive bacteria. The aroA gene encoding EPSP
synthase has been cloned from M. tuberculosis and the predicted protein was shown to
be structurally related with EPSP synthases from other sources (Garbe et al., 1990). The
B. subtilis gene, aroE, encoding EPSP synthase has been cloned, sequenced and
overexpressed. Kinetic studies together with site-directed mutagenesis showed that the
enzyme has allosteric behaviour towards both substrates, a feature not observed with other
known EPSP synthases. Another characteristic was its ability to form several multimers
resulting in several bands upon native gel electrophoresis and activity staining (Majumder
et al., 1995). The activity of EPSP synthase from B. subtilis was inhibited by glyphosate
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(N-(phosphonomethyl)glycine, a broad spectrum herbicide) in vivo and in vitro (Fischer
et al., 1986). Other bacterial and plant EPSP synthases are also inhibited by glyphosate
(Amrhein et al., 1983) but the enzyme of most Pseudomonas species was remarkably
glyphosate resistant (Schulz et al., 1985). Resistance against glyphosate has been found
to correlate with increased synthesis of a sensitive EPSP synthase enzyme or the synthesis
of a mutated, insensitive EPSP synthase (Reinbothe et al., 1991). Cloning of a gene
conferring increased glyphosate resistance in Pseudomonas sp. did not complement an
E. coli strain with an inactivated EPSP synthase. Apparently a desensitized mutated EPSP
synthase is not the only mechanism for glyphosate resistance. Other mechanism may
involve increased export or even degradation of glyphosate (Fitzgibbon and Braymer,
1990).
Genetically defined aroA mutants of (mycobacterial) pathogens may be constructed
via gene replacement. These weakened strains may be used for raising vaccines (Garbe
et al., 1990).
Chorismate synthase
Chorismate synthase (CS) catalyses the conversion of EPSP into chorismate, the end
product of the shikimate pathway. The enzyme requires reduced FMN or FAD but their
role in catalysis is currently unknown (Izumi et al., 1993; Ramjee et al., 1991, 1992).
The N. crassa chorismate synthase is a bifunctional enzyme and is a tetramer with a
subunit Mr of 50,000, larger than the tetrameric E. coli enzyme (Table 2). It has been
proposed that the difference in Mr was due to the presence of a diaphorase domain on the
N. crassa chorismate synthase for the generation of reduced FMN from NADPH (White
et al., 1988). In another eukaryote, S. cerevisiae, chorismate synthase is a monofunctional
enzyme similar to the E. coli enzyme (Jones et al., 1991).
Chorismate synthase has been purified from B. subtilis and was present in a complex
with NADPH-dependent flavin reductase and 3-dehydroquinate synthase (Hasan and
Nester, 1978). The role of the flavin reductase may be in providing reduced FAD or FMN
for the chorismate synthase reaction. The presence of 3-dehydroquinate synthase in the
complex was not required for chorismate synthase activity (Hasan and Nester, 1978;
Haslam, 1993). 3-Dehydroquinate synthase activity, however, was dependent on the
presence of chorismate synthase (Hasan and Nester, 1978). The genes aroB and aroF,
encoding 3-dehydroquinate synthase and chorismate synthase respectively, were both
present in the supra operon aroFBH-trpEDCFBA-hisH-tyrA-aroE. The
NADPH-dependent flavin reductase was not present in the same operon (Babitzke et al.,
1992).
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L-PHE AND L-TYR BIOSYNTHETIC PATHWAYS
The formation of L-Phe or L-Tyr from chorismate involves three enzymatic steps in
both cases (Fig. 4). Chorismate is converted into prephenate via an intramolecular
rearrangement of the pyruvyl sidechain at C-3 to C-1 via the formation of a new bond
between C-9 and C-1. Prephenate can be converted into phenylpyruvate,
4-hydroxyphenylpyruvate or into L-arogenate. The formation of L-arogenate is a classical
amino transfer of the amino group from L-glutamate to the keto group of prephenate.
Conversion of prephenate into phenylpyruvate involves decarboxylation of the C-1
carboxyl group and dehydration of the C-4 hydroxyl resulting in aromatization of the
cyclohexadiene. Formation of 4-hydroxyphenylpyruvate involves the same
decarboxylation but oxidation results in aromatization, keeping the C-4 hydroxyl
unchanged. L-Arogenate can undergo the same reactions as prephenate. Dehydration and
decarboxylation of L-arogenate will yield L-Phe and oxidative decarboxylation L-Tyr.
Transfer of the amino group from L-glutamate to the keto group of phenylpyruvate or
4-hydroxyphenylpyruvate will yield L-Phe or L-Tyr, respectively.
ENZYMOLOGY OF L-PHE AND L-TYR BIOSYNTHESIS
Chorismate mutase
Chorismate mutase catalyses the conversion of chorismate into prephenate.
Chorismate mutase enzymes occur either in a free form (CM-F) or associated with other
proteins (Bentley, 1990). Chorismate mutase may be associated with prephenate
dehydratase (P-protein), prephenate dehydrogenase (T-protein) or DS (DS-CM) (see
above) (Bentley, 1990). The bifunctional E. coli P- and T-proteins possess separate
domains for each activity (Baldwin and Davidson, 1981; Turnbull and Morrison, 1990).
From the bifunctional proteins, active, monofunctional proteins can be constructed
(Stewart et al., 1990; Xia et al., 1992a). The prephenate dehydrogenase domain of the
T-protein can convert both prephenate and arogenate and is therefore referred to as a
cyclohexadienyl dehydrogenase (Ahmad and Jensen, 1987). The P-protein is present in
superfamilies A and B of the Gram-negative bacteria whereas the T-protein has been
detected in the enteric lineage of superfamily A only (Jensen and Ahmad, 1991). CM-F
is present in several Gram-negative bacteria in addition to P-and/or T-proteins (Ahmad
et al., 1990; Bonner et al., 1990; Patel et al., 1977; Xia and Jensen, 1992). This rules out
the possibility that the T-protein originates from a gene fusion between the genes encoding
CM-F and cyclohexadienyl dehydrogenase. Surprisingly, the Erwinia herbicola aroQ
gene product, CM-F, was located in the periplasmic space with a yet unknown function;
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its activity was not feedback inhibited by aromatic amino acids. The AroQ protein is a
positively charged dimer with a subunit Mr of 18,000 and has low homology with other
chorismate mutase enzymes (Xia et al., 1993).
A single, monofunctional chorismate mutase enzyme has been detected in virtually
all tested yeast species and it is exclusively located in the cytosol. Activity of the
chorismate mutase enzyme is regulated via activation by L-Trp and feedback inhibition
by L-Tyr and/or L-Phe (Bode and Birnbaum, 1991). The best characterized enzyme from
eukaryotes is the chorismate mutase from S. cerevisiae. The enzyme is activated by L-Trp
and inhibited by L-Tyr and does not show homology with bacterial chorismate mutases
(Ramilo et al., 1993; Schmidheini et al., 1989). A single amino acid substitution resulted
in a permanently activated, feedback inhibition resistant, chorismate mutase (Graf et al.,
1995; Schmidheini et al., 1989, 1990). The crystal structure of this mutated chorismate








































































Figure 4. Chorismate and beyond- primary metabolic pathways. 1, chorismate mutase; 2,
prephenate/cyclohexadienyl dehydratase; 3, prephenate/cyclohexadienyl dehydrogenase
(NAD(P)+); 4, arogenate/cyclohexadienyl dehydrogenase (NAD(P)+); 5, prephenate/aromatic
amino acid aminotransferase; 6, arogenate/cyclohexadienyl dehydratase.
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chorismate mutase from B. subtilis (Xue and Lipscomb, 1994; Xue et al., 1994). In the
yeast Rhodotorula glutinis two chorismate mutase enzymes were detected; one of these
is feedback inhibited by L-Tyr and activated by L-Trp while the other one is insensitive
towards feedback inhibition or activation (Fiske and Kane, 1984).
The B. subtilis monofunctional chorismate mutase is the best studied chorismate
mutase protein from Gram-positive organisms thus far (Chook et al., 1994; Gray et al.,
1990a; Gray and Knowles, 1994; Rajagopalan et al., 1993). Two chorismate mutase
enzymes are present in B. subtilis; a bifunctional DS-CM protein that forms a trifunctional
complex with shikimate kinase (see above) and a monofunctional protein that is believed
to be the natural chorismate mutase (Kurahashi et al., 1987). The chorismate mutase
activity of the DS-CM protein may be the result of a mutation in the chorismate regulatory
site of DS (see above). The enzyme has been crystallized and its structure was determined
(Chook et al., 1994). Both the monofunctional and the bifunctional chorismate mutase
are not feedback inhibited by L-Phe or L-Tyr (Gray et al., 1990b; Lorence and Nester,
1967). In B. licheniformis two chorismate mutase enzymes were detected but no complex
formation with DS and shikimate kinase as in B. subtilis was observed with either
chorismate mutase (Nasser et al., 1969).
The A. mediterranei chorismate mutase is feedback inhibited by L-Phe and L-Tyr and
slightly activated by L-Trp (Xia and Chiao, 1989). Also in A. methanolica inhibition by
L-Phe and L-Tyr was observed (De Boer et al., 1989). In some other species of the
Actinomycetales chorismate mutase activity is inhibited by L-Tyr and (partly) by L-Trp.
L-Phe had an inhibitory effect on chorismate mutase activity in Dactylosporangium
thailandensis only. In six out of thirteen actinomycete species tested, chorismate mutase
activity was activated by L-Phe (Hund et al., 1987). In Microtetraspora glauca chorismate
mutase was activated by L-Phe and feedback inhibited by L-Tyr and L-Trp (Speth et al.,
1989). Chorismate mutase has been purified from S. aureofaciens; the protein is a trimer
with a subunit Mr of 14,300. Activity was not inhibited by aromatic amino acids or by
shikimate, anthranilate, phenylpyruvate, or 4-hydroxyphenylpyruvate. The protein was
not associated with any other protein (Görisch, 1987; Görisch and Lingens, 1974).
Chorismate mutase in the chloramphenicol producing strain Streptomyces sp. 3022a is a
protein with a Mr of 75,000 and not feedback inhibited by the end products or
intermediates of the shikimate pathway (Lowe and Westlake, 1972).
In B. flavum chorismate mutase is present in a complex with DS (Shiio and Sugimoto,
1979). Chorismate mutase activity of B. flavum (and also of C. glutamicum) is inhibited
by L-Phe or L-Tyr and the inhibition is released by L-Trp (Hagino and Nakayama, 1975;
Sugimoto and Shiio, 1980b). The chorismate mutase of B. flavum is a dimer with subunit




Prephenate dehydratase (PDT)  catalyses the formation of phenylpyruvate from
prephenate. In all members of superfamily A and B of the Gram-negative bacteria
prephenate dehydratase is associated with chorismate mutase in a bifunctional P-protein
(see above).
In Ps. aeruginosa (Fiske et al., 1983) and E. herbicola (Xia et al., 1991) a second
monofunctional prephenate dehydratase was detected. The enzymes differed in their
substrate specificity from the prephenate dehydratase component of the P-protein. Not
only prephenate but also arogenate could be used as a substrate. Prephenate dehydratases
that can use both prephenate and arogenate as substrates are referred to as cyclohexadienyl
dehydratases. The Ps. aeruginosa gene pheC encoding cyclohexadienyl dehydratase has
been cloned and sequenced. The calculated subunit Mr was 30,480 and the native protein
is a dimer (Zhao et al., 1992). Localization studies showed that cyclohexadienyl
dehydratase is present in the periplasmic space (Zhao et al., 1993). In other Gram-negative
bacteria, e.g. E. herbicola, cyclohexadienyl dehydratase is also present in the periplasmic
space (Zhao et al., 1993). Together with the periplasmic chorismate mutase (see above),
a functional pathway from chorismate to phenylpyruvate exists in the periplasm (Xia et
al., 1993; Zhao et al., 1993). A possible function may be to scavenge L-arogenate from
plants since especially members of the plant pathogens, Klebsiella, Erwinia and Serratia
possess the periplasmic cyclohexadienyl dehydratase (Zhao et al., 1993). Recently it was
shown that this cyclohexadienyl dehydratase displays homology with periplasmic
receptor proteins for polar amino acids. These receptor proteins may have a function in
chemotaxis (Tam and Saier, 1993). The function for chorismate to phenylpyruvate
conversion in the periplasmic space is currently not known (Xia et al., 1993).
Cyclohexadienyl dehydratase or P-proteins have never been detected in
Gram-positive bacteria; only monofunctional, prephenate specific dehydratase enzymes
have been reported. In B. subtilis a monofunctional prephenate dehydratase exists which
has some unusual regulatory properties. The enzyme is inhibited by L-Phe and L-Trp and
activated by L-Met and L-Leu. Positive regulators force the protein in a hyperactive,
octameric structure while the negative effectors promote the formation of a dimeric, less
active, structure (Fischer and Jensen, 1987a; Pierson and Jensen, 1974; Riepl and Glover,
1979). Activation by L-Met and L-Leu may contribute to a balanced synthesis of these
hydrophobic amino acids, thereby optimizing the process of protein synthesis (Pierson
and Jensen, 1974).
The prephenate dehydratase encoding gene (pheA) of B. subtilis has been cloned and
sequenced, revealing high homology with prephenate dehydratase from C. glutamicum
and the C-terminus of the P-protein from E. coli (Trach and Hoch, 1989). Prephenate
dehydratase from both C. glutamicum and B. flavum are feedback inhibited by L-Phe and
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L-Trp and activated by L-Tyr. Inhibition or activation did not alter the Mr of these
enzymes, differing from the situation in B. subtilis (Fazel and Jensen, 1980). Hydrophobic
amino acids activated prephenate dehydratase of C. glutamicum only at relatively high
concentrations (Hagino and Nakayama, 1974a). In B. flavum these amino acids did not
affect activity (Sugimoto and Shiio, 1974). The pheA gene, of C. glutamicum has been
cloned and sequenced. The predicted protein has a Mr of 33,740 (Follettie and Sinskey,
1986). Considering the Mr of 260,000, an octamer is the most likely quaternary structure
(Fazel and Jensen, 1980).
Prephenate dehydratase in sporeforming members of the Actinomycetales is feedback
inhibited by L-Phe and activated by L-Tyr. In some members, prephenate dehydratase
activity is inhibited not only by L-Phe but also by L-Tyr (Hund et al., 1987). In A.
mediterranei prephenate dehydratase activity was inhibited by L-Phe and activated by
L-Tyr (Xia and Chiao, 1989). A similar situation was found in A. methanolica (De Boer
et al., 1989). Prephenate dehydratase from Micromonospora glauca was partially purified
as a protein with a Mr of 110,000, inhibited by L-Phe and by the remote effectors L-Tyr
and L-Trp (Speth et al., 1989). The Streptomyces 3022a prephenate dehydratase has a Mr
of 220,000 and its activity is inhibited by L-Phe only (Lowe and Westlake, 1972). In other
Streptomycetes, prephenate dehydratase is feedback inhibited by L-Phe only although
some species did not show any inhibition or activation in the presence of L-Phe or L-Tyr
(Keller et al., 1983).
Prephenate dehydrogenase
Prephenate dehydrogenase (PDH) catalyses the formation of
4-hydroxyphenylpyruvate from prephenate. As is the case for prephenate dehydratase,
prephenate dehydrogenase can exist in three different forms, namely together with
chorismate mutase in a bifunctional T-protein (see above), as a monofunctional,
prephenate specific dehydrogenase, or as cyclohexadienyl dehydrogenase.
The prephenate dehydrogenase enzymes from the yeasts Pichia guilliermondii (Koll
et al., 1988), C. maltosa (Bode and Birnbaum, 1991), and S. cerevisiae (Jones and Fink,
1982) are inhibited by L-Tyr. In C. maltosa and in Neurospora prephenate dehydrogenase
activity is activated by L-Trp (Bode et al., 1984) or by L-Phe, respectively (Catcheside,
1969).
Most cyclohexadienyl dehydrogenases are specific for NAD+ (Ahmad et al., 1990;
Patel et al., 1977; Wood and Ganem, 1990; Zhao et al., 1993) and sensitive to feedback
inhibition by L-Tyr (Byng et al., 1980; Patel et al., 1977; Turnbull et al., 1991). An
allosterically insensitive, NAD+-specific, cyclohexadienyl dehydrogenase has been
characterized from Zymomonas mobilis (Zhao et al., 1993) and from several
Pseudomonas species (Subramaniam et al., 1994).
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In Gram-positive bacteria either an arogenate dehydrogenase (see below) or
prephenate dehydrogenase is present. Both enzymes generally are specific for
L-arogenate or prephenate, respectively, which leads to the conclusion that
cyclohexadienyl dehydrogenases are not present in Gram-positive bacteria. Thus far, the
only exception may be found in Microtetraspora glauca, from which a prephenate
dehydrogenase has been partially purified that coeluted with arogenate dehydrogenase
activity. Both activities were specific for NAD+ and are feedback inhibited to the same
extent by L-Tyr and 4-hydroxymercuribenzoate. These results suggest that this enzyme
is a cyclohexadienyl dehydrogenase (Speth et al., 1989).
Prephenate dehydrogenase activity is present in B. subtilis and activity is feedback
inhibited by L-Tyr (Fischer and Jensen, 1987b). The gene encoding prephenate
dehydrogenase (tyrA) has been cloned and was part of the supra operon
aroFBH-trpEDCFBA-hisH-tyrA-aroE (Babitzke et al., 1992).
In Streptomyces   refuineus, an L-Phe activated   NAD+-dependent prephenate
dehydrogenase activity was detected but no feedback inhibition by L-Tyr was found
(Speedie and Park, 1980). In A. mediterranei prephenate dehydrogenase activity was not
regulated (Xia and Chiao, 1989). In Nocardia sp. 239 prephenate dehydrogenase activity
was feedback inhibited by both L-Phe and L-Tyr (De Boer et al., 1989). Although
prephenate dehydrogenase was detected in C. glutamicum, as judged from prephenate
dependent NAD(P)H formation (Hagino and Nakayama, 1974a). Fazel and Jensen
(1979b) reported that this was based on an assay artefact. The combination of prephenate,
glutamate (present in high concentrations in crude extracts), NAD(P)+, prephenate
aminotransferase and arogenate dehydrogenase also results in prephenate dependent
NAD(P)H formation.
Arogenate dehydrogenase
Arogenate dehydrogenase catalyses the formation of L-Tyr from arogenate. The
enzyme has been detected in a variety of members of the Actinomycetales. NAD+ is the
preferred coenzyme but sometimes NADP+ is also used but with lower efficiencies (Hund
et al., 1987; Keller et al., 1983). In all but one Streptomyces species tested, L-Tyr acts as
a feedback inhibitor and in a single case L-Phe is an activator of enzyme activity (Keller
et al., 1983). In other actinomycetes tested, arogenate dehydrogenase activity was not
feedback inhibited by L-Tyr (Hund et al., 1987).
Arogenate dehydrogenase enzymes have been purified from Actinoplanes
missouriensis and Streptomyces phaeochromogenes. Both enzymes are dimers with a
subunit Mr of 36,000 and 28,100, respectively, and specific for NAD+ and arogenate.
Activity is not feedback inhibited by L-Tyr or any other intermediate in aromatic amino
acid biosynthesis (Hund et al., 1989; Keller et al., 1985).
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Aromatic amino acid aminotransferase
Aromatic aminotransferase catalyses the formation of L-Phe, L-Tyr or arogenate from
respectively phenylpyruvate, 4-hydroxyphenylpyruvate, or prephenate in the presence of
an appropriate amino donor. Pyridoxal 5'-phosphate is used as a cofactor and is frequently
bound to the enzyme. Aromatic amino acid aminotransferases usually employ broad
substrate specificities resulting in the presence of several isoenzymes.
In E. coli three enzymes capable of transaminating L-Phe, L-Tyr (Pittard, 1987), and
prephenate were detected (Bonner et al., 1990). These isoenzymes (aromatic
aminotransferase, aspartate aminotransferase, and branched-chain aminotransferase) are
not only functional in vitro but also in vivo. Mutants blocked in aromatic aminotransferase
still behaved as if they were prototrophs. Only mutants blocked in aspartate
aminotransferase, aromatic aminotransferase plus branched-chain aminotransferase were
auxotrophic for L-Phe and L-Tyr (Gelfand and Steinberg, 1977). In the nitrogen fixing
plant symbionts Rhizobium meliloti and Rhizobium leguminosarum biovar trifolii
multiple aromatic aminotransferases were present (Kittell et al., 1989; Perezgaldona et
al., 1992). Inducible aminotransferases play a role in the catabolism of aromatic amino
acids in Pseudomonas putida (Ziehr and Kula, 1985). In B. subtilis four aromatic amino
acid aminotransferases were detected. Two enzymes were active with L-Phe and L-Tyr
only, whereas the other two were also active with histidinol phosphate and L-Asp
(Mavrides and Comerton, 1978). Histidinol phosphate aminotransferase, active with
aromatic amino acids, was also present in Z. mobilis (Gu et al., 1995).
The thermophilic Bacillus IS1 contained a single, monomeric, thermostable aromatic
aminotransferase, Mr of 45,000, active with L-Tyr and L-Phe but not with L-Asp (Schutten
et al., 1987). Thermostable aromatic aminotransferases have also been characterized from
the hyperthermophilic  archaea Thermococcus  litoralis (Andreotti et  al., 1994) and
Pyrococcus furiosus (Andreotti et al., 1995). Both organisms contain two aromatic
aminotransferases that were specific for L-Phe, L-Tyr, and L-Trp. The aminotransferases
from T. litoralis were  active  as dimers with a subunit Mr of 47,000 and 45,000,
respectively. P. furiosus aro ATI has been purified and characterized as a dimer with a
subunit Mr of 44,000. N-Terminal amino acid sequence analysis revealed that the P.
furiosus aro ATI is similar to aro ATI from T. litoralis. In the archaeon Methanococcus
aeolicus two aromatic aminotransferases were detected; one of these aromatic
aminotransferases coeluted with the branched-chain aminotransferase activity in gel
filtration experiments (Xing and Whitman, 1992).
In the coryneform bacteria C. glutamicum and B. flavum two aromatic  amino
transferases also active with L-Asp and branched-chain amino acids were detected. Both
enzymes were most active with prephenate and glutamate. Surprisingly, L-Phe
biosynthesis seems to be dependent on the availability of L-Leu as donor in the
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aminotransferase reaction whereas prephenate aminotransferase was most active with
L-Glu as donor (Fazel and Jensen, 1979a; Shiio et al., 1982). From Brevibacterium lines
an inducible aromatic aminotransferase was characterized as a key enzyme in nitrogen
metabolism (Lee and Desmazeaud, 1985a, 1985b). Two other constitutive aromatic
aminotransferases were also present, one of which was characterized as aspartate
aminotransferase (Asano et al., 1987).
In S. cerevisiae L-Trp and other aromatic amino acids are degraded via an inducible
aromatic aminotransferase. The single constitutive aromatic aminotransferase present in
S. cerevisiae has most likely a role in L-Phe and L-Tyr biosynthesis (Kradolfer et al.,
1982).
Arogenate dehydratase
Arogenate dehydratase catalyses the formation of L-Phe from arogenate. Arogenate
dehydratases were reported only to be present in Gram-negative bacteria and in
eukaryotes. The enzyme is specific for its substrate and is feedback inhibited by L-Phe
(Zamir et al., 1985).
In the eukaryotic algae Euglena gracilis arogenate dehydratase is exclusively involved
in the biosynthesis of L-Phe (Byng et al., 1981).
In the Gram-negative Pseudomonas diminuta the rare situation exists that the
P-Protein is absent and L-Phe biosynthesis proceeds exclusively via arogenate and not
via phenylpyruvate (Whitaker et al., 1981).
Arogenate dehydratase was reported to be present in the actinomycetes
Micromonospora echinospora and Dactylosporangium thailandesis. Both organisms,
however, also possessed prephenate dehydratase activity, indicating dual pathways
towards L-Phe or the presence of a cyclohexadienyl dehydratase (Hund et al., 1987).
L-TRP BIOSYNTHESIS AND OTHER METABOLITES
FROM CHORISMATE
L-Trp is synthesized from chorismate in five enzymatic steps that are invariant in those
organisms that have been studied to date. Variation is found in the organisation and
regulation of the genes and enzymes in the pathway. A discussion of L-Trp biosynthesis
in various organisms is beyond the scope of this introduction and for a recent review the
reader is referred to Haslam (1993) and references therein.
Chorismate is not only the precursor for aromatic amino acids but also for several
other metabolites (Figs. 3, 4). 4-Aminobenzoate and 4-hydroxybenzoate, the precursors
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for tetrahydrofolate   and benzo- and naphtoquinones, respectively, are directly
synthesized from chorismate. Menaquinone, 2,3-dihydroxybenzoate and salicylate
biosynthesis proceeds via isochorismate. For a detailed description of the biosynthesis of
these metabolites the reader is referred to Haslam (1993) and references therein.
REGULATION OF AROMATIC AMINO ACID
BIOSYNTHESIS
Biosynthesis of aromatic amino acid in most organisms is regulated mainly via
feedback inhibition/activation of enzymes converting the branchpoint intermediates; the
aromatic amino acids themselves are generally involved as effectors. The only exception
to date is the regulation of aromatic amino acid biosynthesis in B. subtilis via chorismate,
prephenate, and non-aromatic amino acids.
In all organisms studied thus far, L-Trp controls its own synthesis mainly via feedback
inhibition of anthranilate synthase (Haslam, 1993).
The regulation of L-Tyr and L-Phe is not that uniform and several mechanisms to
control their levels have evolved (see above).
Attenuation of expression together with TyrR and TrpR controlled repression of the
synthesis of the pathway enzymes also play a role in maintaining sufficient amounts of
aromatic amino acids in E. coli (Gavini and Pulakat, 1991; Pittard, 1987; Pittard and
Davidson, 1991).
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